Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patients Treated in Real Life With VEnetoclax for WAldenström Macroglobulinemia

NCT06200220 is registered in ClinicalTrials.gov with Poitiers University Hospital as lead sponsor.

NCT NCT06200220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06200220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patients Treated in Real Life With VEnetoclax for WAldenström Macroglobulinemia
Lead sponsor
Poitiers University Hospital
Phase
Observational
Overall status
Unknown status
Start date
December 28, 2023
Completion date
December 1, 2025
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

waldenstrom's macroglobulinaemia refractory